BSA Awards

dr-deborah-rathjen-ceo-md-bionomics-australia-gets-biospectrum-asia-pacific-awards-2013-in-the-person-of-the-year-2013-category

Australia’s power woman Deborah Rathjen wins BioSpectrum award

  • Australia
  • |
  • Influencers

Steering Bionomics' focus towards large markets where there is a defined clinical need for new treatments, Dr Rathjen helped it gain global recognition for its multiple drug candidates and targets in the therapeutic areas of cancer, anxiety,... Read more

dr-mark-kendall-co-founder-and-director-vaxxas-australia-winner-of-the-biospectrum-asia-pacific-awards-2013-in-the-emerging-company-of-the-year-2013-category

Vaxxas' painless vaccine delivery tech fetches BioSpectrum...


  • Australia
  • |
  • Influencers
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Prof Mark Kendall, a scientist at the Australian Institute of Bioengineering and Nanotechnology under University of Queensland,... Read more

dr-york-zhu-founder-of-biomics-biotechnologies-china-winner-of-the-biospectrum-asia-pacific-awards-2013-in-the-emerging-company-of-the-year-2013-category

BioSpectrum award winner Biomics uses RNAi for therapeutics...


  • China
  • |
  • Influencers
  • |
  • By Vipul Murarka
  • |
  • 0 Comment

Biomics Biotechnologies, China, founded in February 2006, is on road to be counted as one of Asia's leading RNA interference... Read more

dr-silviu-itescu-formed-mesoblast

Stem cells have much to offer, says Dr Silviu Itescu

  • Australia
  • |
  • Influencers
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

Dr Silviu Itescu formed Mesoblast in 2004 to commercialize orthopedic applications of proprietary adult stem cell technology. As the CEO... Read more

dr-silviu-itescu-formed-mesoblast

Dr Silviu Itescu: Pioneer of adult stem cell therapies

  • Australia
  • |
  • Influencers
  • |
  • By Narayan Kulkarni
  • |
  • 2 Comments

A Quinquagenarian from Australia, Dr Silviu Itescu, is based out of the US and has been traveling tirelessly between New York and Melbourne... Read more

yusuf-hamied-cipla

Dr Yusuf K Hamied: India's generics king

  • India
  • |
  • Influencers
  • |
  • By Nandita Singh & Nayantara Som
  • |
  • 1 Comment

Dr Yusuf K Hamied, CMD of India's largest pharma company, Cipla, has earned many unflattering epithets for building a company that "reverse... Read more

Emerging company of the year award for HistoIndex

HistoIndex sets new standards in fibrosis diagnosis

  • Singapore
  • |
  • News
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

Biopsy has been used as a gold standard for determining the extent of liver disease. But this method has its limitations and many times... Read more

Emerging Company of the Year Award for Mitra Biotech

Mitra Biotech keeps focus on personalized cancer care

  • India
  • |
  • News
  • |
  • By Manasi Vaidya
  • |
  • 0 Comment

Using its proprietary platform technology Oncoprint, India-based Mitra Biotech is developing personalized treatment options for cancer,... Read more

BioSpectrum emerging company award winner TaiMed Biologics

TaiMed Biologics taps on humanized mAb for HIV therapy

  • Taiwan
  • |
  • News
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

Publicly-held biotech company TaiMed Biologics was set up in 2007 with the mission to discover, develop and deliver innovative medicines... Read more

Emerging Company of the Year Award  for Spinifex Pharmaceuticals

Spinifex capitalizes on pain management market

  • Australia
  • |
  • News
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Realizing the need for improved therapies in the highly unmet field of pain management, Australia-based Spinifex has been working on bringing... Read more

Biotech-310x175_copy

SimuGen's toxicity predictor to cut drug discovery costs

  • Malaysia
  • |
  • News
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Due to the rising costs in drug discovery and development and a large proportion of drug failure being associated with absorption, distribution,... Read more

Emerging Company of the Year Award 2012

LegoChem offers new platform in anti-cancer therapy

  • Korea
  • |
  • News
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Korea-based LegoChem Biosciences (LCB) was started in 2006 with the objective to accelerate discovery and development of new small molecule... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X